StockData
Amgen Inc logo

Amgen Inc (AMGN) stock

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3023% above fair value
$438.82−5.07 (-1.14%)

Close on Nov 19, 2026Market cap $237.24BP/E 25.4Yield 2.20%

Amgen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Amgen's shares outstanding was 546M at Sep 30, 2026. For fiscal 2025 it was 542M, up 0.2% from the year before. Over ten years it grew -3.4% a year on average. The highest annual figure on record is 1.12B in fiscal 2007.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025542M+0.2%
FY2024Dec 31, 2024541M+0.6%
FY2023Dec 31, 2023538M-0.6%
FY2022Dec 31, 2022541M-5.6%
FY2021Dec 31, 2021573M-2.9%
FY2020Dec 31, 2020590M-3.1%
FY2019Dec 31, 2019609M-8.4%
FY2018Dec 31, 2018665M-9.5%
FY2017Dec 31, 2017735M-2.5%
FY2016Dec 31, 2016754M-1.6%
FY2015Dec 31, 2015766M-0.5%
FY2014Dec 31, 2014770M+0.7%
FY2013Dec 31, 2013765M-2.8%
FY2012Dec 31, 2012787M-13.7%
FY2011Dec 31, 2011912M-5.5%
FY2010Dec 31, 2010965M-5.5%
FY2009Dec 31, 20091.02B-5.0%
FY2008Dec 31, 20081.07B-4.3%
FY2007Dec 31, 20071.12B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026546M+0.7%
Q2 FY2026Jun 30, 2026544M+0.6%
Q1 FY2026Mar 31, 2026544M+0.6%
Q4 FY2025Dec 31, 2025542M+0.2%
Q3 FY2025Sep 30, 2025542M0.0%
Q2 FY2025Jun 30, 2025541M0.0%
Q1 FY2025Mar 31, 2025541M+0.9%
Q4 FY2024Dec 31, 2024541M+0.6%
Q3 FY2024Sep 30, 2024542M+0.7%
Q2 FY2024Jun 30, 2024541M+0.7%
Q1 FY2024Mar 31, 2024536M-0.4%
Q4 FY2023Dec 31, 2023538M0.0%
Q3 FY2023Sep 30, 2023538M0.0%
Q2 FY2023Jun 30, 2023537M0.0%
Q1 FY2023Mar 31, 2023538M-2.4%
Q4 FY2022Dec 31, 2022538M-4.6%
Q3 FY2022Sep 30, 2022538M-7.4%
Q2 FY2022Jun 30, 2022537M-8.0%
Q1 FY2022Mar 31, 2022551M-6.5%
Q4 FY2021Dec 31, 2021564M-4.7%
Q1 FY2021Mar 31, 2021581M-2.2%
Q4 FY2020Dec 31, 2020584M-4.3%
Q3 FY2020Sep 30, 2020589M-5.9%
Q2 FY2020Jun 30, 2020592M-7.6%
Q1 FY2020Mar 31, 2020594M-8.5%
Q2 FY2019Jun 30, 2019610M-7.6%
Q1 FY2019Mar 31, 2019626M-12.0%
Q4 FY2018Dec 31, 2018641M-11.7%
Q3 FY2018Sep 30, 2018649M-11.5%
Q2 FY2018Jun 30, 2018660M-10.6%
Q1 FY2018Mar 31, 2018711M-4.0%
Q4 FY2017Dec 31, 2017726M-2.2%
Q3 FY2017Sep 30, 2017733M-2.7%
Q2 FY2017Jun 30, 2017738M-2.4%
Q1 FY2017Mar 31, 2017741M–
Q4 FY2016Dec 31, 2016742M–
Q3 FY2016Sep 30, 2016753M–
Q2 FY2016Jun 30, 2016756M–

More Amgen figures

See a number that looks wrong?